Patents Assigned to Laguna Pharmaceuticals, Inc.

PHARMACEUTICAL COMPOSITIONS CONTAINING VANOXERINE AND P450 INHIBITORS AND METHODS OF TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA, RESTORING NORMAL SINUS RHYTHM, PREVENTING RECURRENCE OF CARDIAC ARRHYTHMIA AND MAINTAINING NORMAL SINUS RYTHYM IN MAMMALS THROUGH ADMINISTRATION OF SAID COMPOSITIONS

Publication number: 20160303114

Abstract: Compositions comprising vanoxerine (GBR 12909) and a P450 inhibitor, including compositions of vanoxerine and one or more P450 inhibitors, processes for their preparation thereof, and methods of using the same for treatment of cardiac arrhythmias.

Type: Application

Filed: April 25, 2014

Publication date: October 20, 2016

Applicant: Laguna Pharmaceuticals, Inc.

Inventor: Arthur M. Brown
VANOXERINE FOR SELF-ADMINISTRATION FOR TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA IN MAMMALS

Publication number: 20160038482

Abstract: Methods of administration of vanoxerine wherein a patient, previously and successfully treated for cardiac arrhythmia with vanoxerine is prescribed a further dose for self-administration of a further dose of vanoxerine for treatment of a subsequent occurrence of cardiac arrhythmia.

Type: Application

Filed: April 25, 2014

Publication date: February 11, 2016

Applicant: Laguna Pharmaceuticals, Inc.

Inventors: Arthur M. Brown, Rajesh K. Khosla, Howard C. Dittrich
NOVEL PIPERAZINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS OF TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA, RESTORING NORMAL SINUS RHYTHM, PREVENTING RECURRENCE OF CARDIAC ARRHYTHMIA AND MAINTAINING NORMAL SINUS RHYTHM IN MAMMALS

Publication number: 20150336917

Abstract: Novel piperazine compounds are disclosed. Also disclosed are pharmaceutical compositions containing these compounds and therapeutic methods of treating cardiac arrhythmias in mammals, particularly humans, including terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm using these compounds.

Type: Application

Filed: October 11, 2013

Publication date: November 26, 2015

Applicant: Laguna Pharmaceuticals, Inc.

Inventor: Arthur M. BROWN

VANOXERINE FOR SELF-ADMINISTRATION FOR TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA IN MAMMALS

NOVEL PIPERAZINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS OF TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA, RESTORING NORMAL SINUS RHYTHM, PREVENTING RECURRENCE OF CARDIAC ARRHYTHMIA AND MAINTAINING NORMAL SINUS RHYTHM IN MAMMALS